Detail akcie UV Flu online

Business Summary: UV Flu Technologies, Inc. is engaged in the research, development, manufacturing and sales of air purification systems and products. The Company provides air purification systems in the workplace and at home with technology utilizing high-energy ultraviolet radiation (UV) inside a killing chamber, which destroys airborne bacteria, viruses and allergens. The product also reduces odors and the concentrations of volatile organic compounds (VOCs). The Company's product lines include RX-3000, a hospital-grade high-efficiency particulate air (HEPA) air filter; CR-3000, a construction grade version of the RX-3000; RX-4000, a prototype, metal cabinet wall-mounted commercial version of the RX-3000; RX-4500, a commercial version of the RX-3000, which can cover hospital and casino spaces till approximately 10,000 square feet; RX-6500, a bio-terrorism version of RX-4500, and RX Air Plus, a system that combines the RX-3000 and over two Viratech UV-400s to form an air filtration system.
Financial Summary: BRIEF: For the six months ended 31 March 2016, UV Flu Technologies, Inc. revenues increased 19% to $120K. Net loss decreased 41% to $288K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects General and administrative decrease of 44% to $286K (expense).